Management tracks: Tissue Regenix, Therapix

By BC Staff | Nov 3, 2017 | 10:53 PM GMT

Regenerative medical device company Tissue Regenix Group plc (LSE:TRX) named Steve Couldwell CEO. A Tissue Regenix director since 2013, Couldwell was COO of global biosurgery at Sanofi (Euronext:SAN; NYSE:SNY).

Cannabinoid

Read the full 299 word article

How to gain access

Continue reading with a
two-week free trial.